Reverse transcriptase inhibitors are medications used in the management and treatment of HIV. It is in the antiretroviral class of drugs. This activity reviews the indication, action, and contraindications for RTIs as a valuable agent in managing HIV (and other disorders when applicable). This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional healthcare team in the (management of patients with HIV and related conditions.

**Objectives:**
- Identify the mechanism of action of reverse transcriptase inhibitors.
- Describe the potential adverse effects when patients receive reverse transcriptase inhibitors.
- Review appropriate monitoring during therapy with reverse transcriptase inhibitors.
- Summarize interprofessional team strategies for improving care coordination and communication to advance reverse transcriptase inhibitor use and improve outcomes.